IHL 0.00% 4.1¢ incannex healthcare limited

IHL 675a was originally being touted as a treatment for...

  1. 1,211 Posts.
    lightbulb Created with Sketch. 526
    IHL 675a was originally being touted as a treatment for ARDS/SARDS which is the technical condition for the lung inflammation caused by covid (cytokine storm). Following pre-ind meeting with the FDA, IHL was advised to broaden the trial to include arthritis, IBD, and lung inflammation more broadly.

    Could still be used to treat covid but I believe the market has significantly reduced due to effectiveness of preventative vaccines.

    https://hotcopper.com.au/threads/ann-positive-fda-pre-ind-meeting-guides-ihl-675a-development.6018128/
    Last edited by moguns: 02/05/23
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.